We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Search Results

Showing 41-60 of 1,823 results
  1. Atomoxetine

    Article 08 August 2020
  2. Atomoxetine

    Article 20 June 2020
  3. Nonstimulant Medications for Attention-Deficit/Hyperactivity Disorder (ADHD) in Adults: Systematic Review and Meta-analysis

    Background

    For some adults with Attention-Deficit/Hyperactivity Disorder (ADHD), nonstimulants need to be considered either as a monotherapy or as an...

    Nevena V. Radonjić, Alessio Bellato, ... Stephen V. Faraone in CNS Drugs
    Article 11 May 2023
  4. Psychotherapy, Atomoxetine or Both? Preliminary Evidence from a Comparative Study of Three Types of Treatment for Attention-Deficit/Hyperactivity Disorder in Children

    Background

    The current study aimed to investigate using a superiority framework the efficacy of a combined treatment (cognitive-behavioral therapy...

    Daniel David, Anca Dobrean, ... Manfred Döpfner in Cognitive Therapy and Research
    Article 02 October 2020
  5. The therapeutic role of repetitive transcranial magnetic stimulation in children with attention deficit/hyperactivity disorder in Egypt a randomized sham controlled clinical trial

    Background

    Repetitive transcranial magnetic stimulation showed some evidence for improving symptoms of ADHD along with its relative safety, thus could...

    Nahla Al Sayed Nagy, Ghada Refaat Amin, ... Mostafa Shohdy in Middle East Current Psychiatry
    Article Open access 22 July 2022
  6. Assessment of probiotic strain Lactobacillus acidophilus LB supplementation as adjunctive management of attention-deficit hyperactivity disorder in children and adolescents: a randomized controlled clinical trial

    Background

    This study was designed to examine the possible efficacy of the probiotic strain Lactobacillus acidophilus LB (Lacteol Fort) on...

    Reham M. Elhossiny, Heba H. Elshahawy, ... Reham I. Abdelmageed in BMC Psychiatry
    Article Open access 09 November 2023
  7. Atomoxetine

    Article 14 March 2020
  8. Novel non-stimulants rescue hyperactive phenotype in an adgrl3.1 mutant zebrafish model of ADHD

    ADHD is a highly prevalent neurodevelopmental disorder. The first-line therapeutic for ADHD, methylphenidate, can cause serious side effects...

    Hildur Sóley Sveinsdóttir, Christian Christensen, ... Karl Ægir Karlsson in Neuropsychopharmacology
    Article Open access 18 November 2022
  9. adgrl3.1-deficient zebrafish show noradrenaline-mediated externalizing behaviors, and altered expression of externalizing disorder-candidate genes, suggesting functional targets for treatment

    Externalizing disorders (ED) are a cause of concern for public health, and their high heritability makes genetic risk factors a priority for...

    Barbara D. Fontana, Florian Reichmann, ... Matthew O. Parker in Translational Psychiatry
    Article Open access 02 October 2023
  10. Atomoxetine

    Article 15 February 2020
  11. Pharmacologic Management of Cognitive Disengagement Syndrome (CDS) and Implications for Attention-Deficit/Hyperactivity Disorder (ADHD) Treatment: Emerging Treatments and Recommendations for Future Research

    Although the study of cognitive disengagement syndrome (CDS; previously called sluggish cognitive tempo) first emerged in the 1980s, very little is...

    Kelsey K. Wiggs, Tanya E. Froehlich, Stephen P. Becker in CNS Drugs
    Article 15 April 2023
  12. Pharmacotherapy for ADHD in children and adolescents: A summary and overview of different European guidelines

    Attention deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by a persistent pattern of inattention, hyperactivity,...

    L. Van Vyve, B. Dierckx, ... T. Banaschewski in European Journal of Pediatrics
    Article 14 December 2023
  13. Atomoxetine

    Article 23 November 2019
  14. Atomoxetine

    Article 09 November 2019
  15. Control of sustained attention and impulsivity by Gq-protein signalling in parvalbumin interneurons of the anterior cingulate cortex

    The anterior cingulate cortex (ACC) has been implicated in attention deficit hyperactivity disorder (ADHD). More specifically, an appropriate balance...

    Martin M. Jendryka, Uwe Lewin, ... Dennis Kätzel in Translational Psychiatry
    Article Open access 05 July 2023
  16. Trends in use of attention deficit hyperactivity disorder medication among children and adolescents in Scandinavia in 2010–2020

    The objective of the study was to compare the use of attention deficit hyperactivity disorder (ADHD) medication among children and adolescents in...

    Anne Mette Skov Sørensen, Rikke Wesselhöeft, ... Lotte Rasmussen in European Child & Adolescent Psychiatry
    Article 13 July 2022
Did you find what you were looking for? Share feedback.